YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

GSK pens $20M deal with 23andMe

Posted online

Pharmaceutical company GSK reached a $20 million deal with 23andMe Holding Co.

The agreement gives GSK access to DNA data from the approximately 80% of 23andMe gene-testing customers who agreed to share their information for research.

It expands upon an existing five-year deal under which GSK can access anonymized DNA data.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences